BELUPO lijekovi i kozmetika d.d.
- Address
- Ulica Danica 5
Sponsor Overview
Specializations
Dermatology and Inflammatory Skin Disease
Research activity is centered on localized inflammatory skin disorders that are resistant to standard therapy and require high-potency topical corticosteroids. The sponsor’s clinical interest includes conditions where control of cutaneous inflammation and symptom burden is clinically important.
- Therapy-resistant skin inflammation
- Topical corticosteroid treatment
- Clobetasol propionate formulations
Its trial activity reflects a focused commitment to therapeutic areas involving severe dermatologic inflammation and topical treatment options used in routine skin care.
Topical Formulation and Bioequivalence
The sponsor is involved in clinical research assessing the comparability of topical ointment formulations used in dermatologic therapy. This includes interest in how different preparations of clobetasol propionate perform after skin application in healthy adult subjects.
- Ointment formulation comparison
- Skin application studies
- Vasoconstriction assessment
These research activities are aligned with the development and evaluation of topical medicinal products for skin-directed treatment.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Bioequivalence Study of Clobetasol Propionate 0.5 mg/g Ointments in Localized Therapy-Resistant Inflammatory Skin Diseases in Healthy Adults | Poland | Not Recruiting |
Data & Insights
This sponsor works with 0 molecules, of which 0 are not being studied by other sponsors.
This sponsor has worked with 1 site across their trial portfolio.
Therapeutic Focus
- 1.Skin and Connective Tissue Diseases1 trial247 other sponsors
Partnered Research Centres
1 centre- Address
- Ul. Gładka 22, 02-172 Warsaw
Want to get in touch with this sponsor?
Send a question and we'll pass it on to BELUPO lijekovi i kozmetika d.d..
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.

